- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Adult Hepatocellular Carcinoma
Total 5011 results
-
Cancer Institute and Hospital, Chinese Academy...CompletedAdvanced Hepatocellular CarcinomaChina
-
National Cancer Center, KoreaSamsung Medical CenterUnknownAdvanced Hepatocellular CarcinomaKorea, Republic of
-
University Hospital, BordeauxCompleted
-
Shanghai Zhongshan HospitalWest China Hospital; Tongji Hospital; Anhui Provincial HospitalUnknownHepatocellular Carcinoma (HCC)China
-
Xijing HospitalUnknownAdvanced Hepatocellular CarcinomaChina
-
Medical College of WisconsinNorthwestern University; GuerbetCompletedHepatocellular Carcinoma (HCC)United States
-
University of MiamiSurefire Medical, Inc.WithdrawnUnresectable Hepatocellular CarcinomaUnited States
-
University Hospital, MontpellierCompleted
-
AmgenWithdrawnAdvanced Hepatocellular CarcinomaUnited States
-
Kyowa Kirin Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular Carcinoma
-
Egyptian Society of Liver CancerTerminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
Aegera TherapeuticsChinese University of Hong KongCompletedAdvanced Hepatocellular CarcinomaChina
-
Federico II UniversityOspedali dei ColliCompletedAdvanced Hepatocellular CarcinomaItaly
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; Guangzhou No.12 People's HospitalCompleted
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalUnknown
-
Ain Shams UniversityCompletedHepatoCellular Carcinoma
-
Guangxi Medical UniversityUnknownHepatoCellular CarcinomaChina
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Survival Outcomes | Targeted Therapy | Adverse Effect | Metastatic Cervical Carcinoma | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Objective Response Rate | Overall Survival | Progression-free Survival | Epidermal Growth Factor Receptor | NimotuzumabChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Grupo Español de Investigación en Cáncer de OvarioGlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaboratorsActive, not recruitingRecurrent Ovarian CarcinomaFrance, Spain, Belgium, Italy, Germany
-
Xuanwu Hospital, BeijingChinese PLA General Hospital; The First Hospital of Hebei Medical University; Chifeng Municipal Hospital and other collaboratorsNot yet recruitingRecurrent Adult Tethered Cord SyndromeChina
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerOvarian Endometrioid Adenocarcinoma | Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer and other conditionsUnited States
-
Lee's Pharmaceutical LimitedRecruitingAdvanced Hepatocellular CarcinomaChina
-
Fujian Medical UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Shanghai Changzheng HospitalNot yet recruitingAdvanced Hepatocellular Carcinoma
-
AstraZenecaRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Shantou University Medical CollegeGuangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingSingle-arm, Open-label Clinical Study of SZ003 in the Treatment of Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
-
Wen TianfuRecruitingAdvanced Hepatocellular CarcinomaChina
-
Sun Yat-sen UniversityNot yet recruitingAdvanced Hepatocellular CarcinomaChina
-
Wen LiRecruitingUnresectable Hepatocellular CarcinomaChina
-
Polaris GroupRecruitingHepatocellular Carcinoma | Advanced Hepatocellular CarcinomaTaiwan, Vietnam
-
Yue HanJiangsu HengRui Medicine Co., Ltd.RecruitingHAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE FailureUnresectable Hepatocellular CarcinomaChina
-
Massachusetts General HospitalGenentech, Inc.Not yet recruitingUnresectable Hepatocellular CarcinomaUnited States
-
Fudan UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Massachusetts General HospitalGenentech, Inc.RecruitingHepatocellular Carcinoma | Resectable Hepatocellular CarcinomaUnited States
-
Zhejiang UniversityCARsgen Therapeutics Co., Ltd.RecruitingAdvanced Hepatocellular CarcinomaChina
-
Koo Foundation Sun Yat-Sen Cancer CenterRecruitingHepatocellular Carcinoma (HCC)Taiwan
-
Central South UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Hepatocellular CarcinomaChina
-
Dalin Tzu Chi General HospitalBuddhist Tzu Chi General Hospital; Hualien Tzu Chi General HospitalRecruitingHepatocellular Carcinoma(HCC)Taiwan
-
Anhui Medical UniversityCompleted
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy